NorthWest Biotherapeutics Inc (NWBO)

[hope4patients]

Some back of the napkin math:

5K patients/yr at a total treatment cost of $175K gets you to $13.82/share if you use 950Million shares outstanding and a revenue multiple of 15 (pretty standard).

At 10K patients/yr the value would be $27.63/share.

Outstanding shares will likely be slightly higher after TLD so you can make that adjustment but price for treatment will likely be higher than $175k as well. I believe compassionate use patients are paying about $200K.

The ability to meet demand will be the only factor limiting share price imho.